MIRABILIS THERAPEUTICS
Mirabilis Therapeutics develops the next generation microRNA medicines in the areas of cardiovascular and metabolic disorders. Their mission is to become Europe’s number one microRNA developing and commercializing company, developing high medical need drugs for and in close collaboration with doctors and patients.
MIRABILIS THERAPEUTICS
Industry:
Biotechnology
Founded:
2015-01-01
Address:
Maastricht, Limburg, The Netherlands
Country:
The Netherlands
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
CMC Contrast
CMC Contrast is a drug development company.
Crescita Therapeutics
Crescita Therapeutics is a drug development company.
myriamed
myriamed is a drug development company.
More informations about "Mirabilis Therapeutics"
Mirabilis Therapeutics - Crunchbase Company Profile & Funding
Mirabilis Therapeutics develops the next generation microRNA medicines in the areas of cardiovascular and metabolic disorders. Their mission is to become Europe’s number one …See details»
Paula Da Costa Martins - mirabilis-therapeutics.com
Dr. da Costa Martins focused her research of the last 10 years on unraveling the post-transcriptional regulatory mechanisms leading to pathological cardiac remodeling and …See details»
Investors - mirabilis-therapeutics.com
Mirabilis Therapeutics is currently a privately-held company. For more information on investment possibilities please contact Jan Wit through [email protected].See details»
Mirabilis Therapeutics | VentureRadar
Mirabilis Therapeutics is a drug development company dedicated to the discovery and development of innovative products in the field of cardiovascular diseases and metabolic …See details»
MRB-5000 - Drug Targets, Indications, Patents - Synapse
Understand key drug designations in just a few clicks with Synapse. MRB-5000, Initially developed by Mirabilis Therapeutics BV, Now, its global highest R&D status is Pending, …See details»
New Limburg Start-up to develop treatment for heart …
Jun 2, 2015 · Mirabilis Therapeutics BV, known as Mirabilis, is a new spin-off by Maastricht University and the Maastricht University Medical Centre (UM/MUMC+). Mirabilis focuses on developing new medications...See details»
Mirabilis Therapeutics - Products, Competitors, Financials, …
Mirabilis Therapeutics primarily serves the healthcare sector by developing treatments for conditions with medical needs. It was founded in 2015 and is based in Maastricht, …See details»
Start-up to develop new treatment for heart failure
May 1, 2021 · Our Department exploits their academic findings towards rational therapy development for genetic and acquired forms of heart failure in the Dutch spin-off company …See details»
Mirabilis Therapeutics - Crunchbase
Mirabilis Therapeutics is a drug development company. Start Free Trial . Chrome ExtensionSee details»
Jan Wit - mirabilis-therapeutics.com
Chief Executive Officer and co-founder of Mirabilis-Therapeutics Jan Wit obtained his PhD in Organic Chemistry at the Free university of Amsterdam in 2001. After working several years in …See details»
Mirabilis Therapeutics - Tech Stack, Apps, Patents & Trademarks
Mirabilis Therapeutics is actively using 7 technologies for its website, according to BuiltWith. These include SPF, SSL by Default, and Google Maps.See details»
LncRNA Bigheart trans-activates gene expression in a feed forward ...
Dec 12, 2023 · Our observations confirm that human heart failure arises from specific susceptibilities in gene regulatory circuits that are amenable for therapeutic intervention using …See details»
Mirabilis Therapeutics - VentureRadar
Mirabilis Therapeutics is a drug development company dedicated to the discovery and development of innovative products in the field of cardiovascular diseases and metabolic …See details»
Mirabilis Therapeutics Stock Price, Funding, Valuation, Revenue ...
See Mirabilis Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Mirabilis Therapeutics's post-money valuation and revenue.See details»
Biovector Therapeutics, S.A. - VentureRadar
Similar Companies: Avidas Pharmaceuticals USA n/a n/a. Protein Polymer Technologies Inc. (PPTI) USA n/a n/a Ardena Belgium n/a Ardena is a fully integrated Contract Development & …See details»
Psychedelic-Assisted Therapy Trials – A Northern Ireland First
May 22, 2023 · Mirabilis Health Institute and Transcend Therapeutics have announced the launch of Northern Ireland's first clinical trial for psychedelic-assisted therapySee details»
MRB-9093 - Drug Targets, Indications, Patents - Synapse - Patsnap
MRB-9093, Initially developed by Mirabilis Therapeutics BV, Now, its global highest R&D status is Pending, Therapeutic Areas: Cardiovascular Diseases.See details»
MRB-1004 - Drug Targets, Indications, Patents - Synapse
MRB-1004, Initially developed by Mirabilis Therapeutics BV, Now, its global highest R&D status is Pending, Therapeutic Areas: Endocrinology and Metabolic Disease.See details»
Mirabilis Company Profile 2024: Valuation, Funding & Investors
Developer of a non-invasive therapeutic ultrasound device designed to improve women's health.See details»
MRB-6002 - Drug Targets, Indications, Patents - Synapse - Patsnap
Understand key drug designations in just a few clicks with Synapse. MRB-6002, Initially developed by Mirabilis Therapeutics BV, Now, its global highest R&D status is Pending, …See details»